Melanie Swan

Summary

Publications

  1. pmc Crowdsourced health research studies: an important emerging complement to clinical trials in the public health research ecosystem
    Melanie Swan
    MS Futures Group, Palo Alto, CA 94306, United States
    J Med Internet Res 14:e46. 2012
  2. pmc Emerging patient-driven health care models: an examination of health social networks, consumer personalized medicine and quantified self-tracking
    Melanie Swan
    Research Associate, MS Futures Group, P O Box 61258, Palo Alto, CA 94306, USA
    Int J Environ Res Public Health 6:492-525. 2009
  3. doi request reprint Multigenic condition risk assessment in direct-to-consumer genomic services
    Melanie Swan
    MS Futures Group, Palo Alto, California 94306, USA
    Genet Med 12:279-88. 2010
  4. doi request reprint Meeting report: American Aging Association 40th Annual Meeting, Raleigh, North Carolina, June 3-6, 2011
    Melanie Swan
    MS Futures Group, Palo Alto, CA 94306, USA
    Rejuvenation Res 14:449-55. 2011
  5. doi request reprint Steady advance of stem cell therapies: report from the 2011 World Stem Cell Summit, Pasadena, California, October 3-5
    Melanie Swan
    MS Futures Group, P O Box 61258, Palo Alto, CA 94306, USA
    Rejuvenation Res 14:699-704. 2011

Detail Information

Publications5

  1. pmc Crowdsourced health research studies: an important emerging complement to clinical trials in the public health research ecosystem
    Melanie Swan
    MS Futures Group, Palo Alto, CA 94306, United States
    J Med Internet Res 14:e46. 2012
    ....
  2. pmc Emerging patient-driven health care models: an examination of health social networks, consumer personalized medicine and quantified self-tracking
    Melanie Swan
    Research Associate, MS Futures Group, P O Box 61258, Palo Alto, CA 94306, USA
    Int J Environ Res Public Health 6:492-525. 2009
    ..This paper examines three categories of novel health services: health social networks, consumer personalized medicine and quantified self-tracking...
  3. doi request reprint Multigenic condition risk assessment in direct-to-consumer genomic services
    Melanie Swan
    MS Futures Group, Palo Alto, California 94306, USA
    Genet Med 12:279-88. 2010
    ..In the interim, direct-to-consumer (DTC) genomic companies have forged ahead in developing composite risk interpretations for multigenic conditions. It is useful to understand how variance in risk interpretation may arise...
  4. doi request reprint Meeting report: American Aging Association 40th Annual Meeting, Raleigh, North Carolina, June 3-6, 2011
    Melanie Swan
    MS Futures Group, Palo Alto, CA 94306, USA
    Rejuvenation Res 14:449-55. 2011
    ..Engineered enzymes may be useful in lysosomal catabolism. Dietary restriction mimetics, most promisingly involving target of rapamycin (TOR; TORC1 inhibition and rapamycin), may be more feasible than dietary restriction...
  5. doi request reprint Steady advance of stem cell therapies: report from the 2011 World Stem Cell Summit, Pasadena, California, October 3-5
    Melanie Swan
    MS Futures Group, P O Box 61258, Palo Alto, CA 94306, USA
    Rejuvenation Res 14:699-704. 2011
    ....